Improving Outcomes of Same-sitting Bilateral Flexible Ureteroscopy for Renal Stones in Real-world Practice-Lessons Learnt from Global Multicenter Experience of 1250 Patients.

Flexible ureteroscopy Holmium laser Kidney calculi Laser Lithotripsy Retrograde intrarenal surgery Thulium fiber laser

Journal

European urology open science
ISSN: 2666-1683
Titre abrégé: Eur Urol Open Sci
Pays: Netherlands
ID NLM: 101771568

Informations de publication

Date de publication:
Jun 2023
Historique:
accepted: 29 03 2023
medline: 7 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: epublish

Résumé

Bilateral kidney stones are commonly treated in staged procedures. To evaluate outcomes after same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) for renal stones. Data from adults who underwent bilateral RIRS in 21 centers were retrospectively reviewed (from January 2015 to June 2022). The inclusion criteria were unilateral/bilateral symptomatic bilateral stone(s) of any size/location in both kidneys and bilateral stones on follow-up with symptom/stone progression. Stone-free rate (SFR) was defined as absence of any fragment >3 mm at 3 mo. Continuous variables are presented as medians and 25-75th percentiles. A multivariable logistic regression analysis was performed to evaluate independent predictors of sepsis and bilateral SFR. A total of 1250 patients were included. The median age was 48.0 (36-61) yr. Of the patients, 58.2% were prestented. The median stone diameter was 10 mm on both sides. Multiple stones were present in 45.3% and 47.9% of the left and right kidneys, respectively. Surgery was stopped in 6.8% of cases. The median surgical time was 75.0 (55-90) min. Complications were transient fever (10.7%), fever/infection needing prolonged stay (5.5%), sepsis (2%), and blood transfusion (1.3%). Bilateral and unilateral SFRs were 73.0% and 17.4%, respectively. Female (odds ratio [OR] 2.97, 95% confidence interval [CI] 1.18-7.49, SSB-RIRS is an effective treatment with an acceptable complication rate in selected patients with kidney stones. In this large multicenter study, we looked at outcomes after same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) for renal stones in a large cohort. We found that SSB-RIRS was associated with acceptable morbidity and good stone clearance after a single session.

Sections du résumé

Background UNASSIGNED
Bilateral kidney stones are commonly treated in staged procedures.
Objective UNASSIGNED
To evaluate outcomes after same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) for renal stones.
Design setting and participants UNASSIGNED
Data from adults who underwent bilateral RIRS in 21 centers were retrospectively reviewed (from January 2015 to June 2022). The inclusion criteria were unilateral/bilateral symptomatic bilateral stone(s) of any size/location in both kidneys and bilateral stones on follow-up with symptom/stone progression. Stone-free rate (SFR) was defined as absence of any fragment >3 mm at 3 mo.
Outcome measurements and statistical analysis UNASSIGNED
Continuous variables are presented as medians and 25-75th percentiles. A multivariable logistic regression analysis was performed to evaluate independent predictors of sepsis and bilateral SFR.
Results and limitations UNASSIGNED
A total of 1250 patients were included. The median age was 48.0 (36-61) yr. Of the patients, 58.2% were prestented. The median stone diameter was 10 mm on both sides. Multiple stones were present in 45.3% and 47.9% of the left and right kidneys, respectively. Surgery was stopped in 6.8% of cases. The median surgical time was 75.0 (55-90) min. Complications were transient fever (10.7%), fever/infection needing prolonged stay (5.5%), sepsis (2%), and blood transfusion (1.3%). Bilateral and unilateral SFRs were 73.0% and 17.4%, respectively. Female (odds ratio [OR] 2.97, 95% confidence interval [CI] 1.18-7.49,
Conclusions UNASSIGNED
SSB-RIRS is an effective treatment with an acceptable complication rate in selected patients with kidney stones.
Patient summary UNASSIGNED
In this large multicenter study, we looked at outcomes after same-sitting bilateral retrograde intrarenal surgery (SSB-RIRS) for renal stones in a large cohort. We found that SSB-RIRS was associated with acceptable morbidity and good stone clearance after a single session.

Identifiants

pubmed: 37284041
doi: 10.1016/j.euros.2023.03.018
pii: S2666-1683(23)00195-7
pmc: PMC10240508
doi:

Types de publication

Journal Article

Langues

eng

Pagination

51-59

Informations de copyright

© 2023 The Authors.

Références

Int Braz J Urol. 2013 May-Jun;39(3):387-92
pubmed: 23849570
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Med Life. 2022 Feb;15(2):284-291
pubmed: 35419108
Urology. 2012 Oct;80(4):800-4
pubmed: 22743260
J Urol. 2010 Mar;183(3):1017-21
pubmed: 20092842
World J Urol. 2017 Sep;35(9):1301-1320
pubmed: 28213860
J Endourol. 2021 Apr;35(4):560
pubmed: 33081516
BJU Int. 2019 Nov;124(5):836-841
pubmed: 31166648
J Endourol. 2022 Sep;36(9):1155-1160
pubmed: 35414219
BJU Int. 2013 Mar;111(3):459-66
pubmed: 23253797
World J Urol. 2022 Jun;40(6):1377-1389
pubmed: 35072738
J Endourol. 2015 Aug;29(8):894-8
pubmed: 25706683
J Endourol. 2021 Jan;35(1):14-20
pubmed: 32689826
Urol Clin North Am. 2022 Feb;49(1):1-10
pubmed: 34776044
Urol Clin North Am. 2004 Feb;31(1):71-81
pubmed: 15040403
Curr Urol Rep. 2019 Feb 21;20(3):15
pubmed: 30790070
JAMA Intern Med. 2015 Aug;175(8):1413-6
pubmed: 26121191
Eur Urol Open Sci. 2022 Aug 30;44:84-91
pubmed: 36071820
J Urol. 2013 Feb;189(2):580-4
pubmed: 22982421
World J Urol. 2020 Sep;38(9):2147-2166
pubmed: 31748953
World J Urol. 2023 Feb;41(2):567-574
pubmed: 36536170
J Endourol. 2022 Dec;36(12):1522-1525
pubmed: 36150029
Investig Clin Urol. 2021 Mar;62(2):121-135
pubmed: 33660439
Urolithiasis. 2022 Feb;50(1):71-77
pubmed: 34272594
Eur Urol. 2016 Jul;70(1):188-194
pubmed: 27086502
World J Urol. 2019 Jan;37(1):125-131
pubmed: 29915945
Urology. 2022 Jan;159:41-47
pubmed: 34715241
Urolithiasis. 2019 Oct;47(5):481-486
pubmed: 30448869
Minerva Urol Nephrol. 2021 Aug;73(4):428-430
pubmed: 33949186

Auteurs

Daniele Castellani (D)

Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy.

Olivier Traxer (O)

Department of Urology AP-HP, Sorbonne University, Tenon Hospital, Paris, France.

Deepak Ragoori (D)

Department of Urology, Asian Institute of Nephrology & Urology, Irram Manzil Colony, Hyderabad, Telangana, India.

Andrea Benedetto Galosi (AB)

Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy.

Virgilio De Stefano (V)

Urology Unit, Azienda Ospedaliero-Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy.

Nariman Gadzhiev (N)

Department of Urology, Saint-Petersburg State University Hospital, Saint-Petersburg, Russia.

Yiloren Tanidir (Y)

Department of Urology, School of Medicine, Marmara University, İstanbul, Turkey.

Takaaki Inoue (T)

Department of Urology, Hara Genitourinary Private Hospital, Kobe University, Kobe, Japan.

Esteban Emiliani (E)

Department of Urology, Fundacion Puigvert, Autónomos University of Barcelona, Barcelona, Spain.

Saeed Bin Hamri (SB)

Division of Urology, Department of Surgery, Ministry of the National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

Mohamed Amine Lakmichi (MA)

Department of Urology, University Hospital Mohammed the VIth of Marrakesh, Marrakesh, Morocco.

Chandra Mohan Vaddi (CM)

Department of Urology, Preeti Urology and Kidney Hospital, Hyderabad, India.

Chin Tiong Heng (CT)

Department of Urology, Ng Teng Fong General Hospital, Singapore, Singapore.

Boyke Soebhali (B)

Department of Urology, Abdul Wahab Sjahranie Hospital, Medical Faculty Mulawarman University, Samarinda, Indonesia.

Sumit More (S)

Department of Urology, Sarvodaya Hospital and Research Centre, Faridabad, India.

Vikram Sridharan (V)

Department of Urology, Sree Paduka Speciality Hospital, Thillai Nagar, India.

Mehmet Ilker Gökce (MI)

Department of Urology, Ankara University, School of Medicine, Ankara, Turkey.

Azimdjon N Tursunkulov (AN)

Urology Division, AkfaMedline Hospital, Tashkent, Uzbekistan.

Arvind Ganpule (A)

Department of Urology, Muļjibhai Patel Urological Hospital, Nadiad, Gujarat, India.

Giacomo Maria Pirola (GM)

Urology Department, San Giuseppe Hospital, IRCCS Multimedica, Multimedica Group, Milan, Italy.

Angelo Naselli (A)

Urology Department, San Giuseppe Hospital, IRCCS Multimedica, Multimedica Group, Milan, Italy.

Cemil Aydin (C)

Department of Urology, Hitit University, School of Medicine, Çorum, Turkey.

Fernando Ramón de Fata Chillón (F)

Department of Urology, Clinica Universidad de Navarra, Madrid, Spain.

Catalina Solano Mendoza (CS)

Department of Urology AP-HP, Sorbonne University, Tenon Hospital, Paris, France.
Department of Endourology, Uroclin S.A.S, Medellín, Colombia.

Luigi Candela (L)

Department of Urology AP-HP, Sorbonne University, Tenon Hospital, Paris, France.
Division of Experimental Oncology/Unit of Urology, URI-Urological Research Institute IRCCS Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy.

Ben Hall Chew (BH)

Department of Urology, University of British Columbia, Vancouver, Canada.

Bhaskar Kumar Somani (BK)

Department of Urology, University Hospitals Southampton, NHS Trust, Southampton, UK.

Vineet Gauhar (V)

Department of Urology, Ng Teng Fong General Hospital, Singapore, Singapore.

Classifications MeSH